卷 20, 编号 4 (2015)
- 年: 2015
- 文章: 46
- URL: https://bakhtiniada.ru/1028-9984/issue/view/2385
Articles
Combined positron emission and computer tomography in diagnostics of primary metastases in the lymph nodes of the neck
摘要
6-8
Mammographic screening (state of the art and perspectives)
摘要
9-15
Diagnostic and prognostic significance of non-ribosomal nucleolar B23/nucleophosmin protein expression in smooth muscular tissue of the uterus
16-17
HER2/Neu gene amplification in uteri leiomyosarcoma: frequency, clinical and morphological features, correlation with prognosis
18-18
Expression of apoptotic (p53, bcl-2, bax) and proliferative (Ki-67, topoisomerase IIa, Ag-NFP-proteins) markers in normal and non-small lung cancer samples
18-19
Role of genetic risk factors in breast cancer development in individuals born from the irradiated parents in the population of the Semeysk region
19-19
Immunotherapy of malignant glioma: state of the art and perspective studies
20-21
Significance of area and ploidy determination in papillary thyroid cancer
21-22
Perspectives of histoloploidy measurement in cancer process diagnostics
22-22
Radial cervical carcinoma pathomorphism evaluation based on the cytologic characteristic
22-23
Frequency of 1100delc mutation of CHEK2 in members of "cancer" families in the Altay region
23-24
State of the art and perspectives of mammographic screening of breast cancer
24-25
Use of convolution kernel during computed tomography in pneumonia patients
25-26
Densitometric diagnostics of spheric lung forms using artificial neuron
26-27
Evaluation of infiltration processes in homogeneous environment on the basis of an experimental physical model
27-28
Risk factors and basic prophylaxis of suicidial behavior of cancer patients
28-29
The first experience of robot-assisted surgery of patients with thoracic and mediastinal tumors
29-29
Apoptostic marker (p53, bcl-2, bax) association with clinical pathologic parameters and survival in non-small cell lung carcinoma
29-30
Treatment of patients with resectable colorectal cancer metastases in liver
30-31
Extended liver resections combined with preoperative chimiotherapy in treatment of colorectal cancer metastases with high risk of massive hemorrhage
31-33
Status of cancer care for the population of the Altay region in 2014
33-35
Up-to-date options of surgery of tumor invasion into main blood vessels
36-36
Experience of 3D CT-topometry in radiotherapy planning
36-37
Colon endoprosthesis as a stage in treatment of malignant colon obstruction
37-38
Necessity of intestinal microflora restoration in cancer patients
38-39
Analisis of the prolonged environmental contamination and cancer morbidity in the surroundings of a large Novosibirsk motorway
39-40
Study of luminal b-immune phenotype specifities in groups of sporadic and family breast cancer patients
40-41
An experience of ALK-status determination in non-small cell lung carcinoma by an immunohistochemical method in the Altai Regional Oncology Center
41-41
Surgical techniques in retropubic prostatevesiculectomy for urinary incontinence prophylaxis
41-42
Neuroendocrinal tumors in the Altai region
42-43
Hodgkin lymphoma and pregnancy
43-45
Local hyperthermia in combined cancer patient treatment
45-46
Special features of lymphogenous metastatic dissemination and surgery optimization in thyroid cancer
46-46
Effect of tobacco smocking on the risk of colorectal cancer development
46-48
Immunoregulatory cytokines in ovarian cancer treatment
48-48
Target therapy of non-small lung carcinoma
48-49
Possibility of polyspiral computer tomography in determination of kidney cancer pseudocapsule and making a decision about conserving surgery
49-50
Proliferative and apoptotic processes in peritumoral area of kidney cancer
50-51
Study of peritumoral inflammatory infiltrate density in kidney cancer: prognostic significance
51-51
Prognostic significance of evaluation of peritumoral inflammatory infiltrate density in kidney cancer
51-52
Design of a classification cancer model on the basis of immunosignature technology
52-53
Analysis of antibody repertoire (immunosignatures) peptide microchips in cancer diagnostics
53-54
BRCA 1, BRCA 2 gene mutation determination in inherited breast cancer in the Altai region
54-54
Possibility of early diagnostics with immunosignatures. First clinical results
54-55
Heterozygocity loss in P21 (A1026G and G369C) gene in lung cancer patients
55-55
Levan Archilovich Vashakmadze (on the occasion of his 70 th birthday anniversary)
56-56

